
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
April 11, 2025 | Fox&Cat|artificial intelligence, healthcare AI While AI is reshaping frontline healthcare at pace—spotting cancers, triaging patients, and summarising records—its uptake …
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
The biotech’s ENaBL platform enables cell therapies to be administered through an IV injection
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing …
About us - PMLiVE
DESIGN AND PRODUCTION. Hina Mistry – Designer Email: [email protected] Tel: +44 (0)1372 414 272. Anamaria Popescu – Front-End Developer Email: [email protected] …
21-23 PMLIVE’S TOP PHARMA LIST - PMLiVE’s Top Pharma list – …
Johnson & Johnson has claimed the top spot on the list of Top 25 Pharma Companies based on Global sales. The company reported $54,103m in global revenue in 2023, with this predicted …
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
April 7, 2025 | Mednet|Charity partnership, Press Release Mednet, a digital marketing and brand partner in Pharma, has recently strengthened its partnership with women’s charity Smart …
PME - Home
How AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020. As the realities of COVID-19 hit and lockdown …
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
Advertise; Subscribe; Contact; Publications. PME; PME supplements; Communique; T40; Follow; Follow; Follow; Follow
Novartis to invest $23bn into US-based infrastructure over next …
4 days ago · The commitment will allow the company to produce 100% of its key medicines end-to-end in the US Novartis has unveiled plans to invest $23bn into its US-based infrastructure …
4 Communique Awards 2025 - pme.pmlive.com
PMLiVE’s Top Pharma List is live!; Omnichannel – breaking down the barriers; Rare diseases – improving patient access